Related Experiment Video
Updated: Jan 28, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
Establishment and Characterization of Pemetrexed-resistant NCI-H460/PMT Cells
Yu-Lian Xu1, Xiao-Ming Jiang1, Le-Le Zhang1
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Background:
Pemetrexed (PMT) is a multitargeted antifolate agent that is used for treating patients with Non-Small Cell Lung Cancer (NSCLC). However, patients have presented clinical responses of drug resistance to PMT.
Objective:
This study aimed to explore the underlying mechanisms of PMT resistance in NSCLC cells.
Methods:
PMT-resistant NCI-H460/PMT cells were established by treating with PMT in a concentrationescalation manner. MTT assay and colony formation were performed to detect cell proliferation. Immunofluorescence was used to detect the expression of Ki-67. Transwell assay was performed to measure cell migration ability. qPCR and Western blot were used to detect the mRNA and protein expression levels of indicated genes. Small interfering RNAs (siRNA) were used to knockdown ATP binding cassette subfamily B member 1 (ABCB1) and Thymidylate Synthase (TYMS).
Results:
This study showed that compared with the parental cells, the NCI-H460/PMT cells displayed weakened proliferation and enhanced cell mobility. In addition, the NCI-H460/PMT cells demonstrated cellular senescence, which might result in PMT resistance. The NCI-H460/PMT cells exhibited cross-resistance to other chemotherapeutics, including fluorouracil, paclitaxel, doxorubicin, etoposide and gemcitabine, possibly because of the upregulated expression of ABCB1. However, the ABCB1 knockdown by siRNA failed to eradicate PMT resistance. Moreover, TYMS, a target of PMT, was obviously upregulated in the resistant cells. The genetic silence of TYMS partially abrogated PMT resistance, suggesting that the overexpression of TYMS was a key resistant mechanism of PMT.
Conclusion:
The overexpression of TYMS was an important resistance mechanism of PMT for KRAS-mutated NCI-H460 cells. Cross-resistance to other chemotherapeutics should be considered in addressing PMT resistance.
Insights
Overexpression of Thymidylate Synthase (TYMS) drives pemetrexed (PMT) resistance in Non-Small Cell Lung Cancer (NSCLC) cells. Targeting TYMS may overcome this resistance, while cross-resistance to other drugs necessitates careful consideration.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pemetrexed (PMT) is a crucial antifolate chemotherapy for Non-Small Cell Lung Cancer (NSCLC).
- Acquired resistance to PMT poses a significant clinical challenge in NSCLC treatment.
- Understanding the mechanisms of PMT resistance is vital for developing effective therapeutic strategies.
Purpose of the Study:
- To investigate the molecular mechanisms underlying pemetrexed (PMT) resistance in Non-Small Cell Lung Cancer (NSCLC) cells.
- To identify key molecular targets or pathways involved in conferring PMT resistance.
- To evaluate the role of specific genes, such as ABCB1 and TYMS, in PMT resistance.
Main Methods:
- Establishment of PMT-resistant NCI-H460/PMT cell lines through concentration escalation.
- Assessment of cell proliferation, migration, and senescence using MTT assays, colony formation, immunofluorescence (Ki-67), and Transwell assays.
- Quantitative PCR (qPCR) and Western blot analysis to determine mRNA and protein expression levels of target genes.
- Gene knockdown experiments using small interfering RNA (siRNA) targeting ATP binding cassette subfamily B member 1 (ABCB1) and Thymidylate Synthase (TYMS).
Main Results:
- PMT-resistant cells exhibited altered proliferation and enhanced migration, alongside cellular senescence.
- Cross-resistance to multiple chemotherapeutics was observed, potentially linked to upregulated ABCB1 expression.
- ABCB1 knockdown did not fully restore sensitivity to PMT.
- Significant upregulation of Thymidylate Synthase (TYMS), a direct target of PMT, was identified in resistant cells.
- Genetic silencing of TYMS partially reversed PMT resistance, indicating its critical role.
Conclusions:
- Overexpression of Thymidylate Synthase (TYMS) is a key mechanism driving pemetrexed (PMT) resistance in KRAS-mutated NCI-H460 NSCLC cells.
- The observed cross-resistance to other chemotherapeutics warrants consideration in clinical management of PMT-resistant NSCLC.
- Targeting TYMS presents a potential therapeutic strategy to overcome PMT resistance in NSCLC.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
06:52Characterizing Herbivore Resistance Mechanisms: Spittlebugs on Brachiaria spp. as an Example
Published on: June 19, 2011
Related Concept Videos
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Equivalent Resistance
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...